For the 12 C‐type patients in whom FIRM‐guided ablation resulted in a reduction in SAC by the end of the procedure, the rate of freedom from AF at 1 year was 50%, suggesting that targeted ablation beyond PVI may not improve outcomes in patients with C‐type EGF signatures. This evidence concerns the gene EGF and atrial fibrillation.